Two kinase inhibitors have been recommended by the European Medicines Agency for the treatment of non-small cell lung cancer.

OU Health marked a significant breakthrough for Oklahoma in lung cancer treatment, becoming the first health care system in ...

In a study led by researchers at the NUS Yong Loo Lin School of Medicine, extracellular vesicles loaded with customizable ...

It’s possible to catch a cold or get the flu at any time of year. But the chances of becoming sick increase during cold and ...

Lung cancer is the top cause of cancer-related deaths globally, more prevalent in men, and ranks third among women. Both ...

A new study presents a customised treatment strategy using antisense oligonucleotides (ASOs) to target EGFR mutations in ...

By now, we all know the terrible risks smoking poses to your long-term health. But we’re also all too aware of how hard it is ...

The scientists maintain that lower isoprene levels have been identified as a potential indicator of lung cancer.

Therefore, we focused on targeting lung cancer caused by the mutant EGFR. Currently, drugs known as tyrosine kinase inhibitors are the standard of treatment, and they work by inhibiting the mutant ...

It’s no secret that air pollution is tied to lung disease and cancer, but a new study sheds light on the significant role of ...

Patients with lung cancer who have never smoked are usually diagnosed too late for curative treatment. Pam Dalrymple, ...

SINGAPORE: A local study has unveiled a promising treatment approach for Non-Small Cell Lung Cancer (NSCLC), the most common ...